rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2006-4-17
|
pubmed:abstractText |
To determine the value of loss of the expression of E-cadherin and cadherin-associated molecules as useful markers for both prognosis and bladder recurrence in patients with upper urinary tract cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0302-2838
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
839-45; discussion 845
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16426728-Adult,
pubmed-meshheading:16426728-Aged,
pubmed-meshheading:16426728-Aged, 80 and over,
pubmed-meshheading:16426728-Cadherins,
pubmed-meshheading:16426728-Female,
pubmed-meshheading:16426728-Follow-Up Studies,
pubmed-meshheading:16426728-Humans,
pubmed-meshheading:16426728-Immunohistochemistry,
pubmed-meshheading:16426728-Japan,
pubmed-meshheading:16426728-Male,
pubmed-meshheading:16426728-Middle Aged,
pubmed-meshheading:16426728-Prognosis,
pubmed-meshheading:16426728-Retrospective Studies,
pubmed-meshheading:16426728-Survival Rate,
pubmed-meshheading:16426728-Time Factors,
pubmed-meshheading:16426728-Tumor Markers, Biological,
pubmed-meshheading:16426728-Urinary Bladder Neoplasms,
pubmed-meshheading:16426728-alpha Catenin,
pubmed-meshheading:16426728-beta Catenin,
pubmed-meshheading:16426728-gamma Catenin
|
pubmed:year |
2006
|
pubmed:articleTitle |
The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract.
|
pubmed:affiliation |
Department of Urology, Faculty of Medicine, University of Tokyo, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|